Sientra Sets Estimated IPO Range

Santa Barbara-based Sientra, a developer of aesthetic medicine products, said in an SEC filing last night that it now expects its IPO at between $14.00 and $16.00 per share. Sientra is looking to sell 5 million shares of its stock in an offering on the NASDAQ under the symbol SIEN. Sientra's IPO is being underwritten by Piper Jaffray, Stifel, Leerink Partners, and William Blair. Sientra is backed by Abingworth Bioventures, OrbiMed, Clarus Lifesciences, Private Equity Managers, TIAA, and others. The company makes breast implants, gluteal implants, pectoral implants, and other aesthetic medicine products.